IRIS
TURNATURI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.563
EU - Europa 2.587
AS - Asia 2.245
AF - Africa 430
SA - Sud America 363
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.448
SG - Singapore 1.079
IT - Italia 909
RU - Federazione Russa 783
CN - Cina 609
BR - Brasile 303
IE - Irlanda 233
CI - Costa d'Avorio 232
VN - Vietnam 168
DE - Germania 136
FR - Francia 123
UA - Ucraina 117
KR - Corea 108
SN - Senegal 79
CA - Canada 78
GB - Regno Unito 75
NG - Nigeria 50
IN - India 45
JP - Giappone 40
ES - Italia 36
HK - Hong Kong 33
FI - Finlandia 29
PL - Polonia 28
BD - Bangladesh 25
MX - Messico 25
IQ - Iraq 24
NL - Olanda 23
SE - Svezia 22
ZA - Sudafrica 22
AR - Argentina 20
ID - Indonesia 20
TR - Turchia 20
BE - Belgio 15
KE - Kenya 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
BJ - Benin 9
EC - Ecuador 9
LT - Lituania 9
PK - Pakistan 9
AT - Austria 8
CL - Cile 7
EG - Egitto 7
TN - Tunisia 7
AU - Australia 6
GR - Grecia 6
HU - Ungheria 6
LB - Libano 6
SA - Arabia Saudita 6
CO - Colombia 5
MA - Marocco 5
AZ - Azerbaigian 4
IL - Israele 4
JM - Giamaica 4
PY - Paraguay 4
BG - Bulgaria 3
CR - Costa Rica 3
HR - Croazia 3
IR - Iran 3
OM - Oman 3
TH - Thailandia 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
KG - Kirghizistan 1
LY - Libia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 10.195
Salva come PNG Salva come JPEG
Città #
Dallas 675
Singapore 644
Santa Clara 505
Houston 490
Chandler 451
Moscow 339
Ashburn 265
San Jose 257
Catania 250
Abidjan 232
Dublin 231
Chicago 224
Hefei 135
Boardman 115
Beijing 114
Seoul 108
Jacksonville 85
Dakar 79
Los Angeles 78
Civitanova Marche 70
Council Bluffs 70
Lauterbourg 70
Bremen 62
Andover 61
Cambridge 60
Lawrence 60
Nanjing 57
New York 42
Rome 42
Ho Chi Minh City 41
Buffalo 39
Naples 36
Toronto 36
The Dalles 35
Columbus 34
São Paulo 34
Des Moines 33
Tokyo 31
Hanoi 30
Hong Kong 29
Lagos 28
Wilmington 28
Munich 26
Messina 21
Warsaw 21
Denver 20
London 18
Montreal 18
Phoenix 18
San Giovanni la Punta 18
Brooklyn 17
Atlanta 16
Johannesburg 16
Orem 16
Shenyang 16
Abuja 15
Amsterdam 14
Brussels 14
Da Nang 14
Saint Petersburg 14
Changsha 13
Dong Ket 13
Jakarta 13
Frankfurt am Main 12
Jiaxing 12
Madrid 12
Milan 12
Paternò 12
Poplar 12
Salerno 12
Baghdad 11
San Mateo 11
Falls Church 10
Helsinki 10
Nanchang 10
Ottawa 10
Turku 10
Chennai 9
Cotonou 9
Haiphong 9
Lappeenranta 9
Mexico City 9
Pune 9
Rimini 9
Tianjin 9
Belo Horizonte 8
Bologna 8
Fortaleza 8
Grafing 8
Marseille 8
Paris 8
Pozzallo 8
Rio de Janeiro 8
Seattle 8
Tashkent 8
Washington 8
Brno 7
Cagliari 7
Jinan 7
Palermo 7
Totale 7.000
Salva come PNG Salva come JPEG
Nome #
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 411
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 320
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 202
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 194
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 183
(+)-and (−)-Phenazocine enantiomers: evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects 183
A new Sigma-1 Receptor antagonist in Chronic Pain Treatment: (+)-2R/S-LP2 effects in inflammatory and neuropathic pain 168
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 162
ANTIALLODINIC AND ANTIHYPERALGESIC EFFECTS OF LP1, AN OPIOID MULTITARGET LIGAND, IN INFLAMMATORY AND NEUROPATHIC PAIN STATES 159
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 159
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 157
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 155
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 155
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 152
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand. 151
Influenza del N-sostituente della (–)-cis-N-Normetazocina nella modulazione del profilo funzionale al MOR, DOR e KOR: da agonista ad antagonista attraverso ligandi misti agonisti/antagonisti 150
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 145
Dual MOR/DOR agonist benzomorphan-based compounds for pain relief 145
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 144
Intercellular communication and ion channels in neuropathic pain chronicization 144
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 143
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 141
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 140
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 139
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 139
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 138
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 137
MOR/DOR targeting: an useful strategy in pain management 135
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 133
From plant to bench: natural products as source for analgesic drug development. 131
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 130
LP2 e 2S-LP2: agonisti biased dual target MOR/DOR nel trattamento del dolore cronico 130
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 129
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 129
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 128
Design and synthesis of trans-decahydroisoquinoline derivatives as new tramadol-like ligands 128
Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management 126
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 126
Dual-target ligands and pain: our experience 125
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 125
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 123
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 121
Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect. 119
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 118
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 117
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 115
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 115
Analgesici oppioidi 114
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment 113
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 111
Design, synthesis and biological evaluation of MOR agonist/HDACi hybrid compounds: a new potential therapeutic strategy for persistent pain management 110
Progress in the development of more effective and safer analgesics for pain management 109
Multitarget opioid ligands in pain relief: New players in an old game 108
THE BENZOMORPHAN-BASED COMPOUND LP1 AS A MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 108
The benzomorphan-based compound LP1 is a central acting MOR agonist/DOR antagonist suitable for chronic pain treatment 108
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 108
Evaluation of N-substituent structural variations in opioid receptor profile of LP1. 107
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 105
The Benzomorphan-Based Compound LP1 as Suitable Candidate for Pain Management 103
Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation 102
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 102
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 101
The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures 98
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 97
From agonist to antagonist profile in LP1 analogues through the introduction of different N-substituents in benzomorphan-based ligands 96
Idebenone: Novel strategies to improve its systemic and local efficacy 96
Synthesis and structure-activity relationships of (–)-cis-N-normetazocine-based LP1 derivatives 96
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 93
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics for Pain Treatment 93
Simultaneous activation of mu and delta opioid receptors reduces allodynia and astrocytic connexin 43 in an animal model of neuropathic pain 91
Modulation of opioid receptor profile of LP1 analogues through the introduction of different N-substituents 87
Resveratrol-loaded lipid nanocarriers: Correlation between in vitro occlusion factor and in vivo skin hydrating effect 87
Hybrid MOR agonist/HDACi molecules as potential new drugs for persistant pain management: design, synthesis and biological evaluation 86
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 85
Multitarget MOR/DOR antinociceptive ligands as useful profile in pain management: synthesis and pharmacological studies of 6,7-benzomorphan-based LP2 and its isomers 85
MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain 83
IDEBENONE LOADED LIPID NANOPARTICLES: EVALUATION OF IN VITRO ANTIOXIDANT ACTIVITY AND IN VIVO TOPICAL EFFECTS 80
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 76
NEW PLAYERS IN AN OLD GAME: Pharmacological Evaluation of the Benzomorphan-Based Compound LP1. Design and Synthesis of Conformationally Constrained Compounds as New Tramadol-like Candidates. 74
THE BENZOMORPHAN-BASED LP1 IS A CENTRAL-ACTING MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 73
Synthesis and structure-activity relationships of (-)-cis-N-Normetazocine-based LP1 derivatives 69
NEW BENZOMORPHAN-BASED LP1 LIGAND AS SUITABLE MIXED MOP/DOP RECEPTORS AGONIST FOR CHRONIC PAIN TREATMENT 62
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 29
Totale 10.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 34 31
2021/2022544 43 58 10 17 82 10 73 24 41 24 20 142
2022/20231.239 90 79 32 192 96 165 7 244 220 30 52 32
2023/2024721 33 102 43 32 53 193 35 55 2 23 106 44
2024/20252.298 53 340 113 188 442 307 187 97 125 143 150 153
2025/20264.301 313 225 817 271 645 921 449 98 259 285 18 0
Totale 10.464